Bumetanide-d5
Code | Size | Price |
---|
TAR-T10633-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T10633-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Bumetanide D5 is a deuterium-labeled Bumetanide. Bumetanide is a Na+-K+-Cl- (NKCC1) inhibitor (IC50s: 0.68 and 4.0 uM for hNKCC1A and hNKCC2A).
CAS:
1216739-35-3
Formula:
C17H20N2O5S
Molecular Weight:
369.45
Purity:
0.98
SMILES:
O(C1=C(NCCCC)C=C(C(O)=O)C=C1S(N)(=O)=O)C2=C(C(=C(C(=C2[2H])[2H])[2H])[2H])[2H]
References
Sandstr?m PE1, et al. Evidence for diabetogenic action of bumetanide in mice.Eur J Pharmacol. 1988 May 20;150(1-2):35-41.